Jim Simons
OCRX

Jim Simons’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Jim Simons’s Portfolio OCRX Stock Details OCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-219,100
Closed -$460K – 3557
2016
Q4 		$460K Buy
219,100
+33,300
+18% +$77.7K ﹤0.01% 2787
2016
Q3 		$491K Buy
185,800
+16,700
+10% +$41.7K ﹤0.01% 2819
2016
Q2 		$321K Buy
169,100
+22,700
+16% +$59.7K ﹤0.01% 2928
2016
Q1 		$430K Buy
146,400
+41,300
+39% +$118K ﹤0.01% 2882
2015
Q4 		$328K Buy
105,100
+46,900
+81% +$160K ﹤0.01% 2861
2015
Q3 		$184K Buy
58,200
+23,000
+65% +$88.5K ﹤0.01% 2914
2015
Q2 		$134K Buy
+35,200
New +$135K ﹤0.01% 3058
2015
Q1 		– Sell
-12,549
Closed -$80K – 3454
2014
Q4 		$80K Sell
12,549
-25,600
-67% -$150K ﹤0.01% 2829
2014
Q3 		$187K Sell
38,149
-25,600
-40% -$148K ﹤0.01% 2568
2014
Q2 		$487K Buy
63,749
+26,700
+72% +$213K ﹤0.01% 2336
2014
Q1 		$391K Buy
37,049
+23,100
+166% +$330K ﹤0.01% 2434
2013
Q4 		$181K Buy
+13,949
New +$130K ﹤0.01% 2645
2013
Q3 		– Sell
-9,182
Closed -$52K – 3041
2013
Q2 		$52K Buy
+9,182
New +$57K ﹤0.01% 2693

Other funds holding OCRX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $855M AUM 14.24% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jim Simons's OCRX Position: Q1 2017 in Review

Jim Simons sold out of Ocera Therapeutics, Inc. (OCRX) in Q1 2017, closing a stake of 219,100 shares — an estimated $460K sold.

Jim Simons first reported a position in OCRX in Q2 2013 and held it in 13 quarters. The position peaked at $491K in Q3 2016. 26 funds tracked by Wall St. Rank hold OCRX as of Q1 2017.

  • Jim Simons reported no remaining Ocera Therapeutics, Inc. position as of Q1 2017 after selling out during the quarter.
  • Jim Simons sold 219,100 Ocera Therapeutics, Inc. shares in Q1 2017, an estimated $460K.
  • Jim Simons first reported a position in Ocera Therapeutics, Inc. in Q2 2013 and held it in 13 quarters.
  • Jim Simons's Ocera Therapeutics, Inc. position peaked at $491K in Q3 2016.
  • 26 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q1 2017.

Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.